TR202106518A2 - KORONAVİRÜS (SARS-COV-2 veya COVID-19) KAYNAKLI VİRAL HASTALIKLARIN PROFİLAKSİSİ VE TEDAVİSİ İÇİN BİR FARMASÖTİK ÜRÜN - Google Patents

KORONAVİRÜS (SARS-COV-2 veya COVID-19) KAYNAKLI VİRAL HASTALIKLARIN PROFİLAKSİSİ VE TEDAVİSİ İÇİN BİR FARMASÖTİK ÜRÜN Download PDF

Info

Publication number
TR202106518A2
TR202106518A2 TR2021/006518A TR202106518A TR202106518A2 TR 202106518 A2 TR202106518 A2 TR 202106518A2 TR 2021/006518 A TR2021/006518 A TR 2021/006518A TR 202106518 A TR202106518 A TR 202106518A TR 202106518 A2 TR202106518 A2 TR 202106518A2
Authority
TR
Turkey
Prior art keywords
covid
cov
sars
coronavirus
treatment
Prior art date
Application number
TR2021/006518A
Other languages
English (en)
Inventor
Özselani̇k Seçki̇n
Özselani̇k Meryem
Original Assignee
Ena Farma Saglik Ueruenleri Imalat Ve Dis Ticaret Anonim Sirket
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ena Farma Saglik Ueruenleri Imalat Ve Dis Ticaret Anonim Sirket filed Critical Ena Farma Saglik Ueruenleri Imalat Ve Dis Ticaret Anonim Sirket
Priority to TR2021/006518A priority Critical patent/TR202106518A2/tr
Publication of TR202106518A2 publication Critical patent/TR202106518A2/tr
Priority to PCT/TR2021/051615 priority patent/WO2022220767A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş, insanlarda koronavirüs (COVID-19 (SARS-COV-2)) tedavisi ve/veya önlenmesi ve/veya ve ACE2 reseptörün inhibisyonu için; -önceden belirlenmiş oranlarda herhangi bir uçucu yağdan izole edilmiş veya sentetik olarak elde edilmiş 1,8-sineol (1,8- cineole) saf etken maddesi içeren formülasyona sahip bir farmasötik ürün ile ilgilidir.
TR2021/006518A 2021-04-13 2021-04-13 KORONAVİRÜS (SARS-COV-2 veya COVID-19) KAYNAKLI VİRAL HASTALIKLARIN PROFİLAKSİSİ VE TEDAVİSİ İÇİN BİR FARMASÖTİK ÜRÜN TR202106518A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2021/006518A TR202106518A2 (tr) 2021-04-13 2021-04-13 KORONAVİRÜS (SARS-COV-2 veya COVID-19) KAYNAKLI VİRAL HASTALIKLARIN PROFİLAKSİSİ VE TEDAVİSİ İÇİN BİR FARMASÖTİK ÜRÜN
PCT/TR2021/051615 WO2022220767A1 (en) 2021-04-13 2021-12-30 A pharmaceutical product for prophylaxis and treatment of viral diseases caused by coronavirus (sars-cov-2 or covid-19)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2021/006518A TR202106518A2 (tr) 2021-04-13 2021-04-13 KORONAVİRÜS (SARS-COV-2 veya COVID-19) KAYNAKLI VİRAL HASTALIKLARIN PROFİLAKSİSİ VE TEDAVİSİ İÇİN BİR FARMASÖTİK ÜRÜN

Publications (1)

Publication Number Publication Date
TR202106518A2 true TR202106518A2 (tr) 2021-06-21

Family

ID=77615034

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2021/006518A TR202106518A2 (tr) 2021-04-13 2021-04-13 KORONAVİRÜS (SARS-COV-2 veya COVID-19) KAYNAKLI VİRAL HASTALIKLARIN PROFİLAKSİSİ VE TEDAVİSİ İÇİN BİR FARMASÖTİK ÜRÜN

Country Status (2)

Country Link
TR (1) TR202106518A2 (tr)
WO (1) WO2022220767A1 (tr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023091111A1 (en) * 2021-11-18 2023-05-25 İstanbul Medi̇pol Üni̇versi̇tesi̇ Ace-2 enzyme inhibitory effects of essential oils obtained from the aerial parts of eucalyptus globulus and eucalyptus citriodora plants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048953B2 (en) * 2000-04-03 2006-05-23 Inhalation, Inc. Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023091111A1 (en) * 2021-11-18 2023-05-25 İstanbul Medi̇pol Üni̇versi̇tesi̇ Ace-2 enzyme inhibitory effects of essential oils obtained from the aerial parts of eucalyptus globulus and eucalyptus citriodora plants

Also Published As

Publication number Publication date
WO2022220767A1 (en) 2022-10-20

Similar Documents

Publication Publication Date Title
BR112021009595A2 (pt) Terapia de combinação incluindo um inibidor de krasg12c e um ou mais agentes farmaceuticamente ativos adicionais para o tratamento de cânceres
UY38425A (es) Procesos novedosos para preparar n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-1- isopropil-1h-pirazol-3-sulfonamida y sales de éste
BR112019000796A2 (pt) compostos e métodos para tratamento e prevenção da infecção flavivirus
UY30535A1 (es) Composicion comprendiendo farmacos antirretrovirales y al menos un polimero insoluble en agua, proceso de preparacion y aplicaciones.
SV2018005750A (es) Derivados de compuestos de indol sustituidos como inhibidores de la replicacion virica del dengue
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
MA51431B1 (fr) Dérivés d'oxy-fluoropipéridine utilisés en tant qu'inhibiteur de kinase
WO2021168483A3 (en) Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors
TR202106518A2 (tr) KORONAVİRÜS (SARS-COV-2 veya COVID-19) KAYNAKLI VİRAL HASTALIKLARIN PROFİLAKSİSİ VE TEDAVİSİ İÇİN BİR FARMASÖTİK ÜRÜN
CL2022002566A1 (es) Combinaciones de brimonidina de dosis baja y usos de las mismas. (solicitud divisional de 201903572)
MX2022000411A (es) Composicion farmaceutica que comprende un compuesto de tetrahidropirazolopirimidinona.
BR112018072298A2 (pt) tratamento de infecções pelo vírus da zika usando inibidores da alfa-glicosidase
MX2023002117A (es) Forma amorfa de un inhibidor de malt1 y formulaciones de este.
DOP2023000084A (es) Formulación sólida
A Marathe et al. Herbal cocktail as anti-infective: promising therapeutic for the treatment of viral diseases
MX2022011596A (es) Compuestos para tratar o prevenir una infeccion por coronaviridae y metodos y usos para evaluar la aparicion de una infeccion por coronaviridae.
BR112021000183A8 (pt) Preparação medicinal para uso externo
CO2022016504A2 (es) Inhibidores de glucosilceramidasa no lisosomal y los usos de los mismos
WO2022065970A3 (ko) 천연물 혼합 추출물을 포함하는 코로나바이러스 감염 예방 또는 치료용 조성물
DOP2021000069A (es) Derivados de 4 pirazin-2-ilmetil-morfolina y su uso como medicamento
ZA202100955B (en) Thrombin inhibitors, formulations, and uses thereof
UY31096A1 (es) Composiciones farmacéuticas que comprenden la combinacion de un agente derivado hidrogenado de lipstatina y un agente inhibidor de hmg-coa reductasa
MX2023003087A (es) Compuesto de pirimido pirimidinona y composicion farmaceutica que comprenden el mismo.
CL2022002170A1 (es) Composiciones de palmitato de vitamina a, procesos para su preparación, usos y métodos
EA202193054A1 (ru) Стабильные композиции альбувиртида